Statistics

Total Visits

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor70

Select a period of time:

Number of views in the range

Views
Comprehensive overview of the efficacy and safety of sorafenib in advanced or metastatic renal cell carcinoma after a first tyrosine kinase inhibitor21

Views

Views
September 20253
October 20250
November 20251
December 20255
January 20264
February 20262
March 20266
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States11
United Kingdom5
Brazil1
Chile1
Ecuador1
Finland1
Mexico1
 

Top cities views

Views
San Jose4
Ashburn2
Charlotte1
Helsinki1
Monterrey1
Osorno1
Quito1
Votorantim1